Organ Preservation Market is estimated to reach a value of about US$ 455 Million by the end of 2032 | FMI

The global Organ Preservation Market is expected to be worth US$ 455 million by 2032, growing at a compound annual growth rate of 6.4%.

Organ Preservation Market Overview:

Organ preservation is the practise of preserving healthy organs removed from donors’ bodies. Organs are extracted from the donor’s body, transported, and then transplanted into the recipient’s body without causing significant damage. According to the findings of this study, the rising prevalence of chronic illnesses has a direct impact on the adoption of organ preservation.

Request a Sample of this Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-14363

Attributes Details
Organ Preservation Market CAGR (2022-2032) 6.4%
Organ Preservation Market (2026) US$ 317 Million
Organ Preservation Market (2032) US$ 455 Million

Organ preservation for transplantation has a strong influence on donor organ quality, which has a direct impact on a patient’s morbidity and survival rates following transplantation. One of the major factors driving the growth of the organ preservation solutions market is the increasing prevalence of chronic illnesses, as well as the world’s growing elderly population.

Because of the increasing number of organ failures caused by diabetes, cardiovascular diseases (CVDs), obesity, and other serious medical problems, static cold storage organ preservation treatments are becoming more common. Innovative and sophisticated organ preservation strategies, such as NMP, act as a growth-inducing agent.

In clinical and experimental research, such strategies help to reduce the risk of reperfusion damage after transplantation and improve static cold storage organ preservation results. Furthermore, an increasing number of government and non-government regulations and activities to encourage organ donation are positively impacting the growth of the organ preservation solutions market.

The growing number of people who volunteer to donate their organs for transplantation and research is also propelling the market forward. Other factors, such as increased R&D and significant developments in the global organ preservation market, are expected to significantly contribute to market expansion.

Have a Conversation with an Analyst: https://www.futuremarketinsights.com/ask-question/rep-gb-14363

Key Takeaways:

  • A preservation injury occurs when the liver no longer functions. A liver transplant, also known as a hepatic transplant, has the potential to save someone’s life. A liver transplant may also be recommended by a doctor to a patient who has reached the end stage of liver disease.
  • Individuals who received a liver transplant had an 89% chance of survival after one year, according to an article published in the American Journal of Transplantation. The growing need for organ transplantation is propelling the global organ preservation market across the board.
  • According to the American Transplant Foundation, approximately 114,000 people in the United States are currently on the waiting list for a life-saving organ transplant. Every day, on average, 20 people die due to a lack of available organs for transplantation.

Competition Analysis:

The global organ preservation marketis dominated by companies such as Paragonix Technologies (US), XVIVO Perfusion AB (Sweden), Dr Franz Köhler Chemie GmbH (Germany), Essential Pharmaceuticals, LLC (US), TransMedics (US), OrganOx Limited (UK), 21st Century Medicine (US), Bridge to Life Limited (US), Waters Medical Systems (US), Preservation Solutions (US), Carnamedica (Poland), Transplant Biomedicals (Spain), Institut (Netherlands).

Key Market Segments Covered in the Study:

By Solution:

  • University of Wisconsin Solution (UW Solution)
  • Custodial HTK
  • Perfadex
  • Other Solutions

By Technique:

  • Static Cold Storage
  • Hypothermia Machine Perfusion
  • Normothermic Machine Perfusion

Request for Customization: https://www.futuremarketinsights.com/customization-available/rep-gb-14363

By Organ Type:

  • Kidney
  • Liver
  • Long
  • Heart
  • Pancreas

By End User:

  • Organ Transplant Centres
  • Hospitals
  • Speciality Clinics

Explore FMI’s Extensive Ongoing Coverage on Healthcare Domain:

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedInTwitterBlogs

 

About the Author

Nikhil Kaitwade

Associate Vice President at Future Market Insights, Inc. has over a decade of experience in market research and business consulting. He has successfully delivered 1500+ client assignments, predominantly in Automotive, Chemicals, Industrial Equipment, Oil & Gas, and Service industries.
His core competency circles around developing research methodology, creating a unique analysis framework, statistical data models for pricing analysis, competition mapping, and market feasibility analysis. His expertise also extends wide and beyond analysis, advising clients on identifying growth potential in established and niche market segments, investment/divestment decisions, and market entry decision-making.
Nikhil holds an MBA degree in Marketing and IT and a Graduate in Mechanical Engineering. Nikhil has authored several publications and quoted in journals like EMS Now, EPR Magazine, and EE Times.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may also like these